Tau Screening Study in Patients With Early Symptomatic AD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This protocol is designed to serve as a pre-screening study for subjects who are potentially eligible for Alzheimer\'s Disease (AD) therapeutic trials that require tau imaging for inclusion by means of a flortaucipir F18 Positron Emission Tomography (PET) scan.
Epistemonikos ID: 389eca26ae8f2839b0f17536c4c6644d8437cee4
First added on: May 21, 2024